Astrocytes in neurodegenerative disease

Area of Science:

• Neurobiology
• Cellular Neuroscience
• Neurodegenerative Diseases

Background:

• Astrocytes are essential glial cells supporting central nervous system (CNS) health and function.
• Astrocytic dysfunction, involving loss of homeostatic roles and gain of toxic functions, is increasingly recognized in neurodegenerative diseases.
• Intracellular aggregates within astrocytes are a hallmark of many neurodegenerative conditions, impairing neuronal viability.

Purpose of the Study:

• To review the multifaceted role of astrocytes in the neuropathology of major neurodegenerative diseases.
• To highlight how astrocytic dysfunction contributes to disease onset and progression.
• To focus on astrocytic involvement in Huntington's disease (HD), Parkinson's disease (PD), Alzheimer's disease (AD), and amyotrophic lateral sclerosis (ALS).

Main Methods:

• Literature review of studies investigating astrocyte function in neurodegeneration.
• Analysis of the impact of astrocytic intracellular aggregates on neuronal health.
• Comparative examination of astrocytic roles across different neurodegenerative disease models.

Main Results:

• Astrocytes exhibit both loss of beneficial functions and gain of detrimental functions in neurodegenerative diseases.
• Intracellular aggregates within astrocytes disrupt normal cellular processes and negatively affect neurons.
• Specific examples of astrocytic dysfunction are detailed for HD, PD, AD, and ALS.

Conclusions:

• Astrocytic dysfunction is a significant contributor to the neuropathology of diverse neurodegenerative diseases.
• Understanding astrocytic roles is critical for developing therapeutic strategies targeting neurodegeneration.
• Targeting astrocytic pathways may offer novel treatment avenues for diseases like AD, PD, HD, and ALS.